Daniel A. Gipe

24 papers receiving 3.3k citations

Daniel A. Gipe's Hit Papers

Evinacumab for Homozygous Familial Hypercholesterolemia 2020 · 607 citations
6070+3+7Years since publication200400600

Peers

Daniel A. Gipe
Comparison fields: 5 of 65
  • Surgery 2.6k
  • Cardiology and Cardiovascular Medicine 726
  • Genetics 147
  • Immunology 90
  • Endocrinology, Diabetes and Metabolism 59
Replace Alexis Wilfrid Baass with:
Alexis Wilfrid Baass Canada
Armando Lira Pineda United States
Fatima Akdim Netherlands
Patrick M. Moriarty United States
Tiziana Sampietro Italy
Isabelle L. Ruel Canada
Ovidio Muñiz-Grijalvo Spain
Gissette Reyes‐Soffer United States
José Luis Díaz-Díaz Spain
Nitin Mahajan United States
Daniel A. Gipe relative to Alexis Wilfrid Baass Canada Alexis Wilfrid Baass's profile →
Citations per field
00.5×2×3×4×4.7×
Alexis Wilfrid Baass · 1×
Citations per year

Countries citing papers authored by Daniel A. Gipe

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Gipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Gipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Gipe more than expected).

Fields of papers citing papers by Daniel A. Gipe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Gipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Gipe. The network helps show where Daniel A. Gipe may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel A. Gipe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel A. Gipe Line = papers co-authored together Daniel A. Gipe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Hit paper breakdown →
2017714
2
Evinacumab for Homozygous Familial Hypercholesterolemia
Hit paper breakdown →
2020607
3
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
Hit paper breakdown →
2015479
4
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Hit paper breakdown →
2015409
5
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Hit paper breakdown →
2017277
6 2019205
7 2014180
8 2014127
9 201486
10 202184
11 201973
12 201660
13 202041
14 201617
15 201516
16 201410
17 20168
18 20167
19 20177
20 20173

About Daniel A. Gipe

Daniel A. Gipe is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 25 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (23 papers) and Lipid metabolism and disorders (3 papers). The work is most often cited by research in Surgery (2.6k citations), Cardiology and Cardiovascular Medicine (726 citations), Genetics (147 citations), Immunology (90 citations) and Endocrinology, Diabetes and Metabolism (59 citations). Daniel A. Gipe has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Robert C. Pordy, G. Kees Hovingh, Marie T. Baccara‐Dinet, John J.P. Kastelein, Daniel Gaudet, Kuo-Chen Chan, Poulabi Banerjee, George D. Yancopoulos, Paul Daniel Thompson and John R. Guyton. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, New England Journal of Medicine, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact